| Literature DB >> 17646908 |
M Wiener1, Y Guo, G Patel, B C Fries.
Abstract
Linezolid is currently indicated to treat vancomycin-resistant Enterococcus faecium infections, nosocomial pneumonia caused by Staphylococcus aureus or Streptococcus pneumoniae, complicated and uncomplicated skin and skin structure infections, and community-acquired pneumonia. We report a case of linezolid-induced lactic acidosis during treatment of vancomycin-resistant enterococcal bacteremia after mitral valve replacement and permanent pacemaker implantation. We also review the current literature describing other cases of linezolid-associated hyperlactatemia.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17646908 DOI: 10.1007/s15010-007-6302-x
Source DB: PubMed Journal: Infection ISSN: 0300-8126 Impact factor: 3.553